دورية أكاديمية

Investigation of a Novel Injectable Chitosan Oligosaccharide—Bovine Hydroxyapatite Hybrid Dental Biocomposite for the Purposes of Conservative Pulp Therapy

التفاصيل البيبلوغرافية
العنوان: Investigation of a Novel Injectable Chitosan Oligosaccharide—Bovine Hydroxyapatite Hybrid Dental Biocomposite for the Purposes of Conservative Pulp Therapy
المؤلفون: Mingkai Cai, Jithendra Ratnayake, Peter Cathro, Maree Gould, Azam Ali
المصدر: Nanomaterials, Vol 12, Iss 21, p 3925 (2022)
بيانات النشر: MDPI AG, 2022.
سنة النشر: 2022
المجموعة: LCC:Chemistry
مصطلحات موضوعية: pulp capping, endodontic cement, biocomposite, mineral trioxide aggregate, Chemistry, QD1-999
الوصف: This study aimed to develop injectable chitosan oligosaccharide (COS) and bovine hydroxyapatite (BHA) hybrid biocomposites, and characterise their physiochemical properties for use as a dental pulp-capping material. The COS powder was prepared from chitosan through hydrolytic reactions and then dissolved in 0.2% acetic acid to create a solution. BHA was obtained from waste bovine bone and milled to form a powder. The BHA powder was incorporated with the COS solution at different proportions to create the COS–BHA hybrid biocomposite. Zirconium oxide (ZrO2) powder was included in the blend as a radiopacifier. The composite was characterised to evaluate its physiochemical properties, radiopacity, setting time, solubility, and pH. Fourier-transform infrared spectroscopic analysis of the COS–BHA biocomposite shows the characteristic peaks of COS and hydroxyapatite. Compositional analysis via ICP-MS and SEM-EDX shows the predominant elements present to be the constituents of COS, BHA, and ZrO2. The hybrid biocomposite demonstrated an average setting time of 1 h and 10 min and a pH value of 10. The biocomposite demonstrated solubility when placed in a physiological solution. Radiographically, the set hybrid biocomposite appears to be more radiopaque than the commercial mineral trioxide aggregate (MTA). The developed COS-BHA hybrid biocomposite demonstrated good potential as a pulp-capping agent exhibiting high pH, with a greater radiopacity and reduced setting time compared to MTA. Solubility of the biocomposite may be addressed in future studies with the incorporation of a cross-linking agent. However, further in vitro and in vivo studies are necessary to evaluate its clinical feasibility.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2079-4991
Relation: https://www.mdpi.com/2079-4991/12/21/3925; https://doaj.org/toc/2079-4991
DOI: 10.3390/nano12213925
URL الوصول: https://doaj.org/article/24065d33041d474c8080ae74e285ad6b
رقم الأكسشن: edsdoj.24065d33041d474c8080ae74e285ad6b
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20794991
DOI:10.3390/nano12213925